A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207
| Autor: | Kendall, Michelle A., Andersen, Janet W., van der Horst, Charles |
|---|---|
| Zdroj: | In Contemporary Clinical Trials 2006 27(3):287-294 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect